Page last updated: 2024-08-21

alpha-aminopyridine and Sjogren's Syndrome

alpha-aminopyridine has been researched along with Sjogren's Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asashima, H; Hirota, T; Iizuka-Koga, M; Kondo, Y; Matsui, M; Matsumoto, I; Segawa, S; Sumida, T; Tahara, M; Takahashi, H; Tsuboi, H	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Sjogren's Syndrome

Article	Year
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis. Clinical and experimental immunology, 2017, Volume: 187, Issue:2 Topics: Adoptive Transfer; Aminopyridines; Animals; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Subfamily 1, Group F, Member 3; Peptide Fragments; Receptor, Muscarinic M3; Sialadenitis; Sjogren's Syndrome; Sulfonamides; Th1 Cells; Th17 Cells	2017

Article

Year

RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.

Clinical and experimental immunology, 2017, Volume: 187, Issue:2

Topics: Adoptive Transfer; Aminopyridines; Animals; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Subfamily 1, Group F, Member 3; Peptide Fragments; Receptor, Muscarinic M3; Sialadenitis; Sjogren's Syndrome; Sulfonamides; Th1 Cells; Th17 Cells

2017